At Isopogen, scientific rigour extends beyond the lab. We focus on collaborations with medical specialists to advance clinical development and work to publish this data in peer-reviewed journals.
Below are some of our most recent publications:
- GM Forbes, MJ Sturm, RW Leong, et al. A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn’s Disease Refractory to Biologic Therapy. Clinical Gastroenterology and Hepatology 2014; 12:64–71.
- DC Chambers, D Enever, S Lawrence, MJ Sturm et al. Mesenchymal Stromal Cell Therapy for Chronic Lung allograft dysfunction: Results of a First-in-Man Study. Stem Cells Trans Med 2017; 6:1152-1157.
- J Armitage, D Tan, M Sturm, P Young, K Shaw, D Weiss, Y Moodley. Intravenous administration of mesenchymal stromal cells localises rapidly to the lung and reduces systemic oxidant loads in COPD patients: A phase I pilot study. European Respiratory Journal 2018; DOI: 10.1183/13993003.02369-2017